• Image of RINVOQ medication Image of RINVOQ medication
    • RINVOQ

    • QTY 30
    • 15 MG
    • Tablet ER 24H
    • Near  77381

UPADACITINIB (ue PAD a SYE ti nib) treats autoimmune conditions, such as arthritis, eczema, and ulcerative colitis. It is often used when other medications have not worked well enough or cannot be tolerated. It works by slowing down an overactive immune system. This decreases inflammation.


RINVOQ Lifestyle Interactions

  • Upadacitinib 15mg, Oral tablet, extended release

    Interaction: Grapefruit juice
    Severity: Major
    Notes for Consumers: Do not drink grapefruit juice or eat grapefruit-containing foods while taking Upadacitinib. Side effects from Upadacitinib may get worse. Contact your care team immediately if you experience any new or unusual side effects.
    Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during upadacitinib treatment due to the risk of increased upadacitinib exposure and adverse reactions. Upadacitinib is a CYP3A4 substrate and grapefruit juice is a strong CYP3A4 inhibitor.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.